Panelists discuss how differing disease mechanisms, inflammatory drivers, and clinical priorities across AMD, DME, and RVO ...

Cadmus C. Rich, MD, MBA, as Chief Medical Officer, and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory Board, bring ...

Phase 1a Single Ascending Dose trial remains on track for initial clinical data to be reportedby year end 2025Phase 1b/2 Multiple Ascending Dose ...

Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.

Home OCT and AI significantly improve early detection and treatment adjustments in neovascular AMD, enhancing patient ...

Lotery cautioned that AI's use in eye care has limitations. "AI models may underperform on underrepresented populations, AI trained on specific datasets may not transfer well across clinical settings, ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. China Medical System Holdings ( (HK:0867) ...